European Commission Answer Key Questions on Medicinal Products and Brexit

The European Commission have released a question and answer document on medicinal products relating to the United Kingdom’s withdrawal from the European Union.

The document answers questions relating to marketing authorisation holders, orphan designations, manufacturing sites and pharmacovigilance in the UK.

To read the document from the European Commission, please click here.

Tagged with

Published on 2. June 2017 in News UK